Publications by authors named "Victoria Odowd"

Claim this Profile
A
A broadly-neutralizing antibody against glycoprotein that potentiates the breadth and neutralization potency of other antibodies.
Francesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, Victoria O'Dowd, Amar Parvate

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD1a promotes systemic manifestations of skin inflammation.
Clare S Hardman, Yi-Ling Chen, Marcin Wegrecki, Soo Weei Ng, Robert Murren

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
Melanie Ramberger, Antonio Berretta, Jeanne M M Tan, Bo Sun, Sophia Michael

Brain· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.
Pramila Rijal, Sean C Elias, Samara Rosendo Machado, Julie Xiao, Lisa Schimanski

Cell Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis.
Johanna Steen, Björn Forsström, Peter Sahlström, Victoria Odowd, Lena Israelsson

Arthritis Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully automated primary screening system for the discovery of therapeutic antibodies directly from B cells.
Simon Tickle, Louise Howells, Victoria O'Dowd, Dale Starkie, Kevin Whale

J Biomol Screen· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.
Alison M Clargo, Ashley R Hudson, Welcome Ndlovu, Rebecca J Wootton, Louise A Cremin

MAbs· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation" [J. Mol. Biol. 425 (2013), 577-593].
Daniel Lightwood, Victoria O'Dowd, Bruce Carrington, Vaclav Veverka, Mark D Carr

J Mol Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.
Nicola L Davies, Joanne E Compson, Brendon Mackenzie, Victoria L O'Dowd, Amanda K F Oxbrow

Clin Vaccine Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery, engineering and characterisation of a highly potent anti-human IL-13 fab fragment designed for administration by inhalation.
Daniel Lightwood, Victoria O'Dowd, Bruce Carrington, Vaclav Veverka, Mark D Carr

J Mol Biol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis